qs_id,statement_number,statement
QS20,1,Adults with a new diagnosis of colorectal cancer have testing for Lynch syndrome.
QS20,2,Adults with early rectal cancer discuss the implications of all potential treatment options with their healthcare professional.
QS20,3,Adults with metastatic colorectal cancer suitable for systemic anti-cancer treatment have testing to identify tumours with RAS and BRAF V600E mutations.
QS20,4,Adults who have had potentially curative surgical treatment for non-metastatic colorectal cancer have follow-up for the first 3 years to detect local recurrence and distant metastases.
